Stockscreener 앱 받기
3.20
4.58%
0.14
시간 외 거래:
3.20
전일 마감가:
$3.06
열려 있는:
$3.11
하루 거래량:
257.04K
Relative Volume:
3.46
시가총액:
$44.25M
수익:
-
순이익/손실:
$-10.31M
주가수익비율:
-4.1558
EPS:
-0.77
순현금흐름:
$-12.65M
1주 성능:
+5.61%
1개월 성능:
+7.93%
6개월 성능:
+12.68%
1년 성능:
+0.00%
1일 변동 폭
$3.06
$3.30
1주일 범위
$2.93
$3.30
52주 변동 폭
$1.75
$4.965
Grace Therapeutics Inc Stock (GRCE) Company Profile
명칭
Grace Therapeutics Inc
전화
609-322-1602
주소
103 CARNEGIE CENTER, PRINCETON
GRCE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GRCE
Grace Therapeutics Inc
|
3.20 | 42.32M | 0 | -10.31M | -12.65M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-02 | 개시 | TD Cowen | Buy |
| 2020-09-01 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-07-06 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2020-01-13 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2019-08-29 | 개시 | B. Riley FBR | Buy |
| 2019-07-18 | 개시 | Oppenheimer | Outperform |
| 2019-06-26 | 개시 | H.C. Wainwright | Buy |
모두보기
Grace Therapeutics Inc 주식(GRCE)의 최신 뉴스
Live market analysis of Grace Therapeutics Inc.2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - Newser
Can a trend reversal in Grace Therapeutics Inc. lead to recoveryPortfolio Growth Summary & Capital Efficiency Focused Ideas - Newser
Custom watchlist performance reports with Grace Therapeutics Inc.Trade Ideas & Free Verified High Yield Trade Plans - Newser
Is it time to cut losses on Grace Therapeutics Inc.2025 Geopolitical Influence & Weekly High Momentum Picks - Newser
What are the risks of holding Grace Therapeutics Inc.Weekly Trading Summary & Fast Moving Stock Watchlists - خودرو بانک
Key resistance and support levels for Grace Therapeutics Inc.Market Growth Review & Free AI Powered Buy and Sell Recommendations - Newser
Will Grace Therapeutics Inc. benefit from rising consumer demandJuly 2025 PostEarnings & Stepwise Trade Signal Guides - خودرو بانک
Grace Therapeutics Inc. stock momentum explained2025 Trade Ideas & Fast Exit and Entry Trade Guides - Newser
Automated trading signals detected on Grace Therapeutics Inc.Market Performance Summary & Daily Momentum Trading Reports - Newser
Pattern recognition hints at Grace Therapeutics Inc. upsideFed Meeting & Technical Confirmation Alerts - Newser
Grace Therapeutics Inc. stock chart pattern explainedJuly 2025 Decliners & Consistent Return Strategy Ideas - Newser
What analysts say about Grace Therapeutics Inc. stockQuarterly Portfolio Report & High Return Stock Watch Alerts - خودرو بانک
What is Grace Therapeutics Inc.’s book value per share2025 Year in Review & Free Weekly Watchlist of Top Performers - خودرو بانک
Comparing Grace Therapeutics Inc. in custom built stock radarsQuarterly Portfolio Report & Weekly Setup with ROI Potential - Newser
How high can Grace Therapeutics Inc. stock goPortfolio Risk Report & Weekly Watchlist of Top Performers - Newser
Applying Elliott Wave Theory to Grace Therapeutics Inc.2025 Trading Volume Trends & Real-Time Buy Signal Notifications - Newser
How to manage a losing position in Grace Therapeutics Inc.Trade Analysis Summary & Long-Term Capital Growth Strategies - Newser
Grace Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Highlights & Real-Time Buy Signal Notifications - Newser
Grace Therapeutics Announces Presentation at The H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
Grace Therapeutics Inc. stock volume spike explainedExit Point & Entry Point Confirmation Signals - Newser
Tick level data insight on Grace Therapeutics Inc. volatility2025 Year in Review & Free Community Consensus Stock Picks - Newser
Can Grace Therapeutics Inc. maintain sales growthWeekly Investment Report & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Predicting Grace Therapeutics Inc. trend using moving averagesMarket Volume Summary & Free Technical Pattern Based Buy Signals - Newser
Can Grace Therapeutics Inc. maintain its current growth rateWeekly Stock Summary & Reliable Breakout Stock Forecasts - خودرو بانک
What is the Moat Score of Grace Therapeutics Inc.2025 Geopolitical Influence & Weekly High Return Stock Opportunities - خودرو بانک
Can trapped investors hope for a rebound in Grace Therapeutics Inc.Earnings Overview Summary & Safe Entry Point Identification - Newser
How to forecast Grace Therapeutics Inc. trends using time series2025 Short Interest & Capital Efficiency Focused Ideas - Newser
Advanced analytics toolkit walkthrough for Grace Therapeutics Inc.July 2025 PreEarnings & Risk Controlled Daily Trade Plans - Newser
Using portfolio simulators with Grace Therapeutics Inc. includedJuly 2025 News Drivers & Consistent Growth Stock Picks - Newser
How Grace Therapeutics Inc. stock performs during market volatilityTrade Analysis Summary & Short-Term High Return Strategies - Newser
Is Grace Therapeutics Inc. stock bottoming out2025 Market Trends & Low Drawdown Trading Techniques - Newser
Short interest data insights for Grace Therapeutics Inc.Market Movement Recap & Low Risk Investment Opportunities - Newser
Will Grace Therapeutics Inc. see short term momentumExit Point & Verified Short-Term Trading Plans - Newser
Grace Therapeutics Inc.’s volatility index tracking explainedGap Up & Community Consensus Stock Picks - Newser
Is Grace Therapeutics Inc. forming bullish engulfing patternsWeekly Risk Report & Fast Gain Swing Alerts - خودرو بانک
Evaluating Grace Therapeutics Inc. with trendline analysisWeekly Stock Recap & Daily Profit Maximizing Tips - Newser
Published on: 2025-09-02 06:57:13 - Newser
Should you hold or exit Grace Therapeutics Inc. nowM&A Rumor & Safe Capital Growth Stock Tips - Newser
Grace Therapeutics Inc (GRCE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):